{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:35:40Z","timestamp":1792888540757,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00210-026-05719-6","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:23:58Z","timestamp":1784777038000},"page":"21521-21536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liposomes-enabled gemcitabine therapy for breast cancer: in vitro and in vivo studies"],"prefix":"10.1007","volume":"399","author":[{"given":"Ali","family":"Al-Shammari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani M. El","family":"Sisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0082-4160","authenticated-orcid":false,"given":"Amr Gamal","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahira F.","family":"El-Menshawe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"1-2","key":"5719_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijpharm.2015.03.020","volume":"485","author":"AA Abdelbary","year":"2015","unstructured":"Abdelbary AA, AbouGhaly MH (2015) Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box\u2013Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm 485(1\u20132):235\u2013243","journal-title":"Int J Pharm"},{"key":"5719_CR2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S105016","volume":"11","author":"IM Abdulbaqi","year":"2016","unstructured":"Abdulbaqi IM, Darwis Y, Khan NAK, Abou Assi R, Khan AA (2016) Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine 11:2279. https:\/\/doi.org\/10.2147\/IJN.S105016","journal-title":"Int J Nanomedicine"},{"key":"5719_CR3","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.2147\/IJN.S381353","volume":"17","author":"KM AbouElhassan","year":"2022","unstructured":"AbouElhassan KM, Sarhan HA, Hussein AK, Taye A, Ahmed YM, Safwat MA (2022) Brain targeting of citicoline sodium via hyaluronic acid-decorated novel nano-transbilosomes for mitigation of Alzheimer\u2019s disease in a rat model: formulation, optimization, in vitro and in vivo assessment. Int J Nanomedicine 17:6347","journal-title":"Int J Nanomedicine"},{"key":"5719_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105686","volume":"96","author":"HA Abou-Taleb","year":"2024","unstructured":"Abou-Taleb HA, Zaki RM, Hefny AA, Afzal O, Shahataa MG, El-Ela FIA, Salem HF, Fouad AG (2024) In vitro and in vivo evaluation of isoxsuprine loaded invasomes for efficient treatment of diabetes-accelerated atherosclerosis. J Drug Deliv Sci Technol 96:105686","journal-title":"J Drug Deliv Sci Technol"},{"key":"5719_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/1178223420951193","volume":"14","author":"V Akhouri","year":"2020","unstructured":"Akhouri V, Kumar A, Kumari M (2020) Antitumour property of Pterocarpus santalinus seeds against DMBA-induced breast cancer in rats. Breast Cancer Basic Clin Res 14:1178223420951193. https:\/\/doi.org\/10.1177\/1178223420951193","journal-title":"Breast Cancer Basic Clin Res"},{"issue":"1","key":"5719_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.15171\/apb.2017.002","volume":"7","author":"M Alavi","year":"2017","unstructured":"Alavi M, Karimi N, Safaei M (2017) Application of various types of liposomes in drug delivery systems. Adv Pharm Bull 7(1):3. https:\/\/doi.org\/10.15171\/apb.2017.002","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"5719_CR7","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1080\/10717544.2022.2072412","volume":"29","author":"ZA Awan","year":"2022","unstructured":"Awan ZA, AlGhamdi SA, Alhakamy NA, Okbazghi SZ, Alfaleh MA, Badr-Eldin SM, Aldawsari HM, Abourehab MA, Asfour HZ, Zakai SA (2022) Optimized 2-methoxyestradiol invasomes fortified with apamin: a promising approach for suppression of A549 lung cancer cells. Drug Deliv 29(1):1536\u20131548. https:\/\/doi.org\/10.1080\/10717544.2022.2072412","journal-title":"Drug Deliv"},{"key":"5719_CR8","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1007\/s11095-012-0783-8","volume":"29","author":"WY Ayen","year":"2012","unstructured":"Ayen WY, Kumar N (2012) In vivo evaluation of doxorubicin-loaded (PEG) 3-PLA nanopolymersomes (PolyDoxSome) using DMBA-induced mammary carcinoma rat model and comparison with marketed LipoDox\u2122. Pharm Res 29:2522\u20132533. https:\/\/doi.org\/10.1007\/s11095-012-0783-8","journal-title":"Pharm Res"},{"key":"5719_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-016-3003-0","volume":"78","author":"J Ciccolini","year":"2016","unstructured":"Ciccolini J, Serdjebi C, Peters GJ, Giovannetti E (2016) Pharmacokinetics and pharmacogenetics of gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective. Cancer Chemother Pharmacol 78:1\u201312","journal-title":"Cancer Chemother Pharmacol"},{"key":"5719_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.biopha.2018.04.079","volume":"103","author":"MF Dias","year":"2018","unstructured":"Dias MF, de Figueiredo BCP, Teixeira-Neto J, Guerra MCA, Fialho SL, Cunha AS (2018) In vivo evaluation of antitumoral and antiangiogenic effect of imiquimod-loaded polymeric nanoparticles. Biomed Pharmacother 103:1107\u20131114","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5719_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S2221-1691(14)60231-8","volume":"4","author":"RC Ekeanyanwu","year":"2014","unstructured":"Ekeanyanwu RC, Njoku OU (2014) Acute and subacute oral toxicity study on the flavonoid rich fraction of Monodora tenuifolia seed in albino rats. Asian Pac J Trop Biomed 4(3):194\u2013202. https:\/\/doi.org\/10.1016\/S2221-1691(14)60231-8","journal-title":"Asian Pac J Trop Biomed"},{"key":"5719_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124684","volume":"665","author":"R El-Bakry","year":"2024","unstructured":"El-Bakry R, Mahmoud DM, Attia ME, Fouad AG, Mohammed NH, Belal A, Miski SF, Albezrah NKA, Mahmoud TM (2024) Improving the targeting and therapeutic efficacy of anastrazole for the control of breast cancer: in vitro and in vivo characterization. Int J Pharm 665:124684. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124684","journal-title":"Int J Pharm"},{"issue":"11","key":"5719_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111306","volume":"15","author":"FIA El-Ela","year":"2022","unstructured":"El-Ela FIA, Gamal A, Elbanna HA, ElBanna AH, Salem HF, Tulbah AS (2022) In vitro and in vivo evaluation of the effectiveness and safety of amygdalin as a cancer therapy. Pharmaceuticals (Basel) 15(11):1306. https:\/\/doi.org\/10.3390\/ph15111306","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"5719_CR14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s13346-023-01412-w","volume":"14","author":"AG Fouad","year":"2024","unstructured":"Fouad AG, Ali MR, Naguib DM, Farouk HO, Zanaty MI, El-Ela FIA (2024) Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis. Drug Deliv Transl Res 14(2):474\u2013490","journal-title":"Drug Deliv Transl Res"},{"key":"5719_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101556","volume":"56","author":"FA Gamal","year":"2020","unstructured":"Gamal FA, Kharshoum RM, Sayed OM, El-Ela FIA, Salem HF (2020) Control of basal cell carcinoma via positively charged ethosomes of Vismodegib: in vitro and in vivo studies. J Drug Deliv Sci Technol 56:101556","journal-title":"J Drug Deliv Sci Technol"},{"issue":"10","key":"5719_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101560","volume":"13","author":"A Gamal","year":"2021","unstructured":"Gamal A, Saeed H, El-Ela FIA, Salem HF (2021) Improving the antitumor activity and bioavailability of sonidegib for the treatment of skin cancer. Pharmaceutics 13(10):1560. https:\/\/doi.org\/10.3390\/pharmaceutics13101560","journal-title":"Pharmaceutics"},{"issue":"5","key":"5719_CR17","first-page":"110","volume":"3","author":"MU Ghori","year":"2015","unstructured":"Ghori MU, Mahdi MH, Smith AM, Conway BR (2015) Nasal drug delivery systems: an overview. Am J Pharmacol Sci 3(5):110\u2013119","journal-title":"Am J Pharmacol Sci"},{"issue":"3","key":"5719_CR18","first-page":"41","volume":"1","author":"MM Hamzeloo","year":"2014","unstructured":"Hamzeloo MM, Taiebi N, Mosaddegh M, Eslami TB, Esmaeili S (2014) The effect of some cosolvents and surfactants on viability of cancerous cell lines. Res J Pharmacogn 1(3):41\u201345","journal-title":"Res J Pharmacogn"},{"issue":"3","key":"5719_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1586\/14737140.5.3.429","volume":"5","author":"V Heinemann","year":"2005","unstructured":"Heinemann V (2005) Gemcitabine in metastatic breast cancer. Expert Rev Anticancer Ther 5(3):429\u2013443","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"5719_CR20","doi-asserted-by":"publisher","first-page":"085","DOI":"10.7324\/JAPS.2013.3516","volume":"3","author":"MA Hossain","year":"2013","unstructured":"Hossain MA, Alam S, Paul P (2013) Development and evaluation of sustained release matrix tablets of indapamide using Methocel K15M CR. J Appl Pharm Sci 3(5):085\u2013090. https:\/\/doi.org\/10.7324\/JAPS.2013.3516","journal-title":"J Appl Pharm Sci"},{"key":"5719_CR21","doi-asserted-by":"crossref","unstructured":"Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN (2012) Chitosan\u2013Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomed 1851\u20131863","DOI":"10.2147\/IJN.S26365"},{"issue":"4","key":"5719_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/pharmaceutics13040587","volume":"13","author":"AT Iacob","year":"2021","unstructured":"Iacob AT, Lupascu FG, Apotrosoaei M, Vasincu IM, Tauser RG, Lupascu D, Giusca SE, Caruntu I-D, Profire L (2021) Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers. Pharmaceutics 13(4):587. https:\/\/doi.org\/10.3390\/pharmaceutics13040587","journal-title":"Pharmaceutics"},{"issue":"3","key":"5719_CR23","first-page":"457","volume":"35","author":"W Iffat","year":"2016","unstructured":"Iffat W, Shoaib MH, Yousuf RI, Ali T, Shakeel S (2016) Post market in vitro release profile study and cost comparison of different nicorandil brands available in Karachi. Pakistan Lat Am J Pharm 35(3):457\u2013462","journal-title":"Pakistan Lat Am J Pharm"},{"issue":"5","key":"5719_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/toxics9050092","volume":"9","author":"Y Ilieva","year":"2021","unstructured":"Ilieva Y, Dimitrova L, Zaharieva MM, Kaleva M, Alov P, Tsakovska I, Pencheva T, Pencheva-El Tibi I, Najdenski H, Pajeva I (2021) Cytotoxicity and microbicidal activity of commonly used organic solvents: a comparative study and application to a standardized extract from Vaccinium macrocarpon. Toxics 9(5):92. https:\/\/doi.org\/10.3390\/toxics9050092","journal-title":"Toxics"},{"key":"5719_CR25","doi-asserted-by":"crossref","unstructured":"Inkoom A, Ndemazie N, Smith T, Frimpong E, Bulusu R, Poku R, Zhu X, Han B, Trevino J, Agyare E (2022) Application of modified gemcitabine-loaded solid lipid nanoparticle in the treatment of pancreatic cancer patient-derived xenograft model","DOI":"10.21203\/rs.3.rs-1777458\/v1"},{"issue":"2","key":"5719_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.colsurfb.2010.07.047","volume":"81","author":"Y Javadzadeh","year":"2010","unstructured":"Javadzadeh Y, Ahadi F, Davaran S, Mohammadi G, Sabzevari A, Adibkia K (2010) Preparation and physicochemical characterization of naproxen\u2013PLGA nanoparticles. Colloids Surf B Biointerfaces 81(2):498\u2013502","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5719_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/B978-0-12-407190-2.00003-4","volume":"119","author":"A Jezierska-Drutel","year":"2013","unstructured":"Jezierska-Drutel A, Rosenzweig SA, Neumann CA (2013) Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res 119:107\u2013125","journal-title":"Adv Cancer Res"},{"issue":"1","key":"5719_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/fcp.12397","volume":"33","author":"B Karimi","year":"2019","unstructured":"Karimi B, Ashrafi M, Shomali T, Yektaseresht A (2019) Therapeutic effect of simvastatin on DMBA-induced breast cancer in mice. Fundam Clin Pharmacol 33(1):84\u201393","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"5719_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/08982104.2019.1610435","volume":"30","author":"RA Khallaf","year":"2020","unstructured":"Khallaf RA, Aboud HM, Sayed OM (2020) Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation. J Liposome Res 30(2):163\u2013173","journal-title":"J Liposome Res"},{"issue":"7","key":"5719_CR30","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1080\/01635581.2023.2219027","volume":"75","author":"YB Laskar","year":"2023","unstructured":"Laskar YB, Bhattacharjee K, Nath M, Choudhury Y, Mazumder PB, Talukdar AD (2023) Protective effects of pelargonidin against DMBA-induced mammary tumorigenesis in BALB\/c mice through reduced oxidative stress and lipid anomalies. Nutr Cancer 75(7):1579\u20131599","journal-title":"Nutr Cancer"},{"issue":"11","key":"5719_CR31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, Zeng H, Zhou J, Wei W (2021) Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun 41(11):1183\u20131194","journal-title":"Cancer Commun"},{"issue":"1","key":"5719_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejpb.2012.05.011","volume":"82","author":"G Li","year":"2012","unstructured":"Li G, Fan Y, Fan C, Li X, Wang X, Li M, Liu Y (2012) Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm 82(1):49\u201357. https:\/\/doi.org\/10.1016\/j.ejpb.2012.05.011","journal-title":"Eur J Pharm Biopharm"},{"key":"5719_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2017.03.039","volume":"254","author":"MO Mahmoud","year":"2017","unstructured":"Mahmoud MO, Aboud HM, Hassan AH, Ali AA, Johnston TP (2017) Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. J Control Release 254:10\u201322","journal-title":"J Control Release"},{"issue":"5","key":"5719_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3109\/10717544.2013.860502","volume":"22","author":"P Nandini","year":"2015","unstructured":"Nandini P, Doijad R, Shivakumar H, Dandagi P (2015) Formulation and evaluation of gemcitabine-loaded solid lipid nanoparticles. Drug Deliv 22(5):647\u2013651","journal-title":"Drug Deliv"},{"key":"5719_CR35","doi-asserted-by":"publisher","DOI":"10.35333\/jrp.2020.115","author":"A \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk A, Ayg\u00fcl A (2020) Design of cefaclor monohydrate containing nanoparticles with extended antibacterial effect by nano-spray dryer: a nanoenglobing study. J Res Pharm. https:\/\/doi.org\/10.35333\/jrp.2020.115","journal-title":"J Res Pharm"},{"key":"5719_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-013-2124-1","volume":"15","author":"NM Patro","year":"2013","unstructured":"Patro NM, Devi K, Pai RS, Suresh S (2013) Evaluation of bioavailability, efficacy, and safety profile of doxorubicin-loaded solid lipid nanoparticles. J Nanopart Res 15:1\u201318","journal-title":"J Nanopart Res"},{"key":"5719_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijbiomac.2019.02.005","volume":"129","author":"V Piazzini","year":"2019","unstructured":"Piazzini V, Landucci E, D\u2019Ambrosio M, Fasiolo LT, Cinci L, Colombo G, Pellegrini-Giampietro DE, Bilia AR, Luceri C, Bergonzi MC (2019) Chitosan coated human serum albumin nanoparticles: a promising strategy for nose-to-brain drug delivery. Int J Biol Macromol 129:267\u2013280","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"5719_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm85030029","volume":"85","author":"M Porwal","year":"2017","unstructured":"Porwal M, Khan NA, Maheshwari KK (2017) Evaluation of acute and subacute oral toxicity induced by ethanolic extract of Marsdenia tenacissima leaves in experimental rats. Sci Pharm 85(3):29. https:\/\/doi.org\/10.3390\/scipharm85030029","journal-title":"Sci Pharm"},{"issue":"9","key":"5719_CR39","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2174\/187152012803529646","volume":"12","author":"J Prados","year":"2012","unstructured":"Prados J, Melguizo C, Ortiz R, V\u00e9lez C, Alvarez JP, Arias LJ, Ruiz AM, Gallardo V, Aranega A (2012) Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. Anti-Cancer Agents Med Chem (Formerly Curr Med Chem-Anti-Cancer Agents) 12(9):1058\u20131070. https:\/\/doi.org\/10.2174\/187152012803529646","journal-title":"Anti-Cancer Agents Med Chem (Formerly Curr Med Chem-Anti-Cancer Agents)"},{"key":"5719_CR40","doi-asserted-by":"publisher","DOI":"10.5114\/bta.2020.100420","author":"D Pylypenko","year":"2020","unstructured":"Pylypenko D, Gorbach T, Krasnopolsky Y (2020) Study of antioxidant activity of liposomal forms of quercetin and curcumin in ischemic heart disease. Biotechnologia. https:\/\/doi.org\/10.5114\/bta.2020.100420","journal-title":"Biotechnologia"},{"key":"5719_CR41","unstructured":"Raghupathy R, Amirthagadeswaran K (2014). Optimization of casting process based on Box Behnken design and response surface methodology. Int J Qual Res 8(4)"},{"issue":"2","key":"5719_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/1735-5362.310528","volume":"16","author":"AH Ramadhani","year":"2021","unstructured":"Ramadhani AH, Ahkam AH, Suharto AR, Jatmiko YD, Tsuboi H, Rifa\u2019i M (2021) Suppression of hypoxia and inflammatory pathways by Phyllanthus niruri extract inhibits angiogenesis in DMBA-induced breast cancer mice. Res Pharm Sci 16(2):217\u2013226. https:\/\/doi.org\/10.4103\/1735-5362.310528","journal-title":"Res Pharm Sci"},{"issue":"05","key":"5719_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1055\/s-0035-1546291","volume":"31","author":"LM Ritschl","year":"2015","unstructured":"Ritschl LM, Fichter AM, H\u00e4berle S, von Bomhard A, Mitchell DA, Wolff K-D, M\u00fccke T (2015) Ketamine-xylazine anesthesia in rats: intraperitoneal versus intravenous administration using a microsurgical femoral vein access. J Reconstr Microsurg 31(05):343\u2013347","journal-title":"J Reconstr Microsurg"},{"key":"5719_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s13346-018-0499-3","volume":"8","author":"HF Salem","year":"2018","unstructured":"Salem HF, Kharshoum RM, Abo El-Ela FI, Abdellatif KR (2018) Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer. Drug Deliv Transl Res 8:633\u2013644. https:\/\/doi.org\/10.1007\/s13346-018-0499-3","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"5719_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/08982104.2019.1601213","volume":"30","author":"HF Salem","year":"2020","unstructured":"Salem HF, Kharshoum RM, Gamal FA, Abo El-Ela FI, Abdellatif KR (2020) Treatment of breast cancer with engineered novel pH-sensitive triaryl-(Z)-olefin niosomes containing hydrogel: an in vitro and in vivo study. J Liposome Res 30(2):126\u2013135. https:\/\/doi.org\/10.1080\/08982104.2019.1601213","journal-title":"J Liposome Res"},{"issue":"10","key":"5719_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101633","volume":"13","author":"HF Salem","year":"2021","unstructured":"Salem HF, Gamal A, Saeed H, Tulbah AS (2021) The impact of improving dermal permeation on the efficacy and targeting of liposome nanoparticles as a potential treatment for breast cancer. Pharmaceutics 13(10):1633. https:\/\/doi.org\/10.3390\/pharmaceutics13101633","journal-title":"Pharmaceutics"},{"issue":"3","key":"5719_CR47","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.xphs.2021.11.007","volume":"111","author":"HF Salem","year":"2022","unstructured":"Salem HF, Ali AA, Hegazy AM, Sadek A-RA, Aboud HM (2022a) Harnessing of doxylamine succinate\/pyridoxine hydrochloride-dual laden bilosomes as a novel combinatorial nanoparadigm for intranasal delivery: in vitro optimization and in vivo pharmacokinetic appraisal. J Pharm Sci 111(3):794\u2013809","journal-title":"J Pharm Sci"},{"issue":"2","key":"5719_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/ph15020126","volume":"15","author":"HF Salem","year":"2022","unstructured":"Salem HF, Gamal A, Saeed H, Kamal M, Tulbah AS (2022b) Enhancing the bioavailability and efficacy of vismodegib for the control of skin cancer: in vitro and in vivo studies. Pharmaceuticals 15(2):126. https:\/\/doi.org\/10.3390\/ph15020126","journal-title":"Pharmaceuticals"},{"key":"5719_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-1626-2","volume":"21","author":"OM Sayed","year":"2020","unstructured":"Sayed OM, Abo El-Ela FI, Kharshoum RM, Salem HF (2020) Treatment of basal cell carcinoma via binary ethosomes of vismodegib: in vitro and in vivo studies. AAPS PharmSciTech 21:1\u201311","journal-title":"AAPS PharmSciTech"},{"key":"5719_CR50","doi-asserted-by":"crossref","unstructured":"Seyedi S, Teo R, Foster L, Saha D, Mina L, Northfelt D, Anderson KS, Shibata D, Gatenby R, Cisneros L (2023) Testing adaptive therapy protocols using gemcitabine and capecitabine on a mouse model of endocrine-resistant breast cancer. bioRxiv","DOI":"10.1101\/2023.09.18.558136"},{"key":"5719_CR51","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.biopha.2017.09.059","volume":"95","author":"A Shafei","year":"2017","unstructured":"Shafei A, El-Bakly W, Sobhy A, Wagdy O, Reda A, Aboelenin O, Marzouk A, El Habak K, Mostafa R, Ali MA (2017) A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer. Biomed Pharmacother 95:1209\u20131218. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.059","journal-title":"Biomed Pharmacother"},{"issue":"1-2","key":"5719_CR52","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ijpharm.2013.11.017","volume":"460","author":"L-N Shen","year":"2014","unstructured":"Shen L-N, Zhang Y-T, Wang Q, Xu L, Feng N-P (2014) Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm 460(1\u20132):280\u2013288. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.11.017","journal-title":"Int J Pharm"},{"key":"5719_CR53","doi-asserted-by":"crossref","unstructured":"Singh AK, Singh A, Madhv NS (2012) Nasal cavity, a promising transmucosal platform for drug delivery and research approaches from nasal to brain targetting. J Drug Deliv Ther 2(3)","DOI":"10.22270\/jddt.v2i3.163"},{"issue":"12","key":"5719_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12121160","volume":"12","author":"D Skourtis","year":"2020","unstructured":"Skourtis D, Stavroulaki D, Athanasiou V, Fragouli PG, Iatrou H (2020) Nanostructured polymeric, liposomal and other materials to control the drug delivery for cardiovascular diseases. Pharmaceutics 12(12):1160","journal-title":"Pharmaceutics"},{"issue":"2","key":"5719_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/pharmaceutics15020591","volume":"15","author":"M Tanori","year":"2023","unstructured":"Tanori M, Pitaro M, Fratini E, Colantoni E, Amoresano A, Celentano S, Chiaramonte B, Mancuso M (2023) Safety in rats of a novel nasal spray formulation for the prevention of airborne viral infections. Pharmaceutics 15(2):591","journal-title":"Pharmaceutics"},{"issue":"3","key":"5719_CR56","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","volume":"65","author":"E Touitou","year":"2000","unstructured":"Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ethosomes\u2014novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65(3):403\u2013418. https:\/\/doi.org\/10.1016\/S0168-3659(99)00222-9","journal-title":"J Control Release"},{"issue":"7","key":"5719_CR57","first-page":"2920","volume":"12","author":"M Tufail","year":"2022","unstructured":"Tufail M, Cui J, Wu C (2022) Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches. Am J Cancer Res 12(7):2920","journal-title":"Am J Cancer Res"},{"issue":"9","key":"5719_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091929","volume":"14","author":"W Xu","year":"2022","unstructured":"Xu W, Deng Z, Xiang Y, Zhu D, Yi D, Mo Y, Liu Y, Qin L, Huang L, Wan B (2022) Preparation, characterization and pharmacokinetics of tolfenamic acid-loaded solid lipid nanoparticles. Pharmaceutics 14(9):1929. https:\/\/doi.org\/10.3390\/pharmaceutics14091929","journal-title":"Pharmaceutics"},{"issue":"1","key":"5719_CR59","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/10837450.2017.1357733","volume":"23","author":"TE Yalcin","year":"2018","unstructured":"Yalcin TE, Ilbasmis-Tamer S, Ibisoglu B, \u00d6zdemir A, Ark M, Takka S (2018) Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity. Pharm Dev Technol 23(1):76\u201386","journal-title":"Pharm Dev Technol"},{"key":"5719_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-020-00903-z","volume":"20","author":"R Zahedi","year":"2020","unstructured":"Zahedi R, Molavi Vardanjani H, Baneshi MR, Haghdoost AA, Malekpour Afshar R, Ershad Sarabi R, Tavakoli F, Zolala F (2020) Incidence trend of breast cancer in women of eastern Mediterranean region countries from 1998 to 2019: a systematic review and meta-analysis. BMC Womens Health 20:1\u201310","journal-title":"BMC Womens Health"},{"key":"5719_CR61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12272-012-0112-0","volume":"35","author":"J-P Zhang","year":"2012","unstructured":"Zhang J-P, Wei Y-H, Zhou Y, Li Y-Q, Wu X-A (2012) Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride: a comparative study. Arch Pharm Res 35:109\u2013117. https:\/\/doi.org\/10.1007\/s12272-012-0112-0","journal-title":"Arch Pharm Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05719-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05719-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05719-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:02:16Z","timestamp":1792886536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05719-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":61,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5719"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05719-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of Beni-Suef University (BSU-IACUC: 022\u2013451).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors refrained from performing any research with humans.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}